CC
VCNX

Courier Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Courier Capital’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48
Closed -$3.56K – 370
2023
Q2 		$3.56K Buy
+48
New +$3.99K ﹤0.01% 360

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Courier Capital's VCNX Position: Q3 2023 in Review

Courier Capital sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2023, closing a stake of 48 shares — an estimated $3.56K sold.

Courier Capital first reported a position in VCNX in Q2 2023 and held it in 1 quarter. The position peaked at $3.56K in Q2 2023. 18 funds tracked by Wall St. Rank hold VCNX as of Q3 2023.

  • Courier Capital reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Courier Capital sold 48 Vaccinex, Inc. Common Stock shares in Q3 2023, an estimated $3.56K.
  • Courier Capital first reported a position in Vaccinex, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Courier Capital's Vaccinex, Inc. Common Stock position peaked at $3.56K in Q2 2023.
  • 18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2023.

Based on Courier Capital's 13F filing for Q3 2023, filed 13 Oct 2023.